Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Phenotype C0008313|sclerosing cholangitis
Sentences 6
PubMedID- 26061393 Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis.
PubMedID- 22221173 Conclusions: long-term high dose ursodeoxycholic acid does not prevent colorectal cancer or dysplasia in patients with primary sclerosing cholangitis-associated inflammatory bowel disease.
PubMedID- 23663396 Apart from subgroups with early onset, extensive and long-standing inflammation, or primary sclerosing cholangitis the risk of developing colorectal cancer is of the same magnitude as in the background population.
PubMedID- 23665966 We performed a systematic review and meta-analysis of studies evaluating the effect of udca on the risk of ibd-associated colorectal neoplasia (crn) (defined as colorectal cancer and/or dysplasia) in patients with primary sclerosing cholangitis with concomitant ibd (psc-ibd).
PubMedID- 25350705 Apart from subgroups with early onset, extensive and long-standing inflammation, or primary sclerosing cholangitis the risk of developing colorectal cancer is of the same magnitude as in the background population.
PubMedID- 25636976 colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Page: 1